Cardiovascular toxicity of Fruquintinib in patients with colorectal and other cancers: a systematic review and meta-analysis
Abstract Background Fruquintinib is a highly selective tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, which play a critical role in angiogenesis and tumor growth. As a novel anti-angiogenic agent, Fruquintinib has demonstrated promising effic...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-09-01
|
| Schriftenreihe: | Cardio-Oncology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s40959-025-00347-0 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|